{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:31:35Z","timestamp":1781713895443,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00192-015-2802-x","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T10:28:01Z","timestamp":1438165681000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cannabinoid receptor expression in the bladder is altered in detrusor overactivity"],"prefix":"10.1007","volume":"27","author":[{"given":"Evangelia","family":"Bakali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Tincello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"2802_CR1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/1352458510378020","volume":"16","author":"RB Kavia","year":"2010","unstructured":"Kavia RB, De Ridder D, Constantinescu CS, Stott CG, Fowler CJ (2010) Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 16:1349\u20131359","journal-title":"Mult Scler"},{"key":"2802_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","volume":"17","author":"RM Freeman","year":"2006","unstructured":"Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D et al (2006) The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 17:636\u2013641","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"2802_CR3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/17460440903018857","volume":"4","author":"K Ahn","year":"2009","unstructured":"Ahn K, Johnson DS, Cravatt BF (2009) Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discovery 4:763\u2013784","journal-title":"Expert Opin Drug Discovery"},{"key":"2802_CR4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00192-012-1954-1","volume":"24","author":"E Bakali","year":"2013","unstructured":"Bakali E, Elliott RA, Taylor AH, Willets J, Konje JC et al (2013) Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J Pelvic Floor Dysfunct 24:855\u2013863","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"2802_CR5","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.juro.2008.11.079","volume":"181","author":"C Gratzke","year":"2009","unstructured":"Gratzke C, Streng T, Park A, Christ G, Stief CG et al (2009) Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181:1939\u20131948","journal-title":"J Urol"},{"key":"2802_CR6","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.juro.2008.11.078","volume":"181","author":"V Tyagi","year":"2009","unstructured":"Tyagi V, Philips BJ, Su R, Smaldone MC, Erickson VL et al (2009) Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181:1932\u20131938","journal-title":"J Urol"},{"key":"2802_CR7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.urology.2008.03.044","volume":"72","author":"MH Hayn","year":"2008","unstructured":"Hayn MH, Ballesteros I, de Miguel F, Coyle CH, Tyagi S et al (2008) Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 72:1174\u20131178","journal-title":"Urology"},{"key":"2802_CR8","doi-asserted-by":"crossref","first-page":"1514.e15","DOI":"10.1016\/j.urology.2009.12.051","volume":"75","author":"G Mukerji","year":"2010","unstructured":"Mukerji G, Yiangou Y, Agarwal SK, Anand P (2010) Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 75:1514.e15\u20131514.e20","journal-title":"Urology"},{"key":"2802_CR9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuroscience.2009.01.050","volume":"159","author":"JS Walczak","year":"2009","unstructured":"Walczak JS, Price TJ, Cervero F (2009) Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience 159:1154\u20131163","journal-title":"Neuroscience"},{"key":"2802_CR10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0703229","volume":"129","author":"RS Martin","year":"2000","unstructured":"Martin RS, Luong LA, Welsh NJ, Eglen RM, Martin GR et al (2000) Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol 129:1707\u20131715","journal-title":"Br J Pharmacol"},{"key":"2802_CR11","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/j.1476-5381.1996.tb15643.x","volume":"118","author":"RG Pertwee","year":"1996","unstructured":"Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053\u20132058","journal-title":"Br J Pharmacol"},{"key":"2802_CR12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.eururo.2010.02.027","volume":"57","author":"C Gratzke","year":"2010","unstructured":"Gratzke C, Streng T, Stief CG, Downs TR, Alroy I et al (2010) Effects of Cannabinor, a novel selective Cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol 57:1093\u20131100","journal-title":"Eur Urol"},{"key":"2802_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.urology.2007.02.069","volume":"70","author":"S Hiragata","year":"2007","unstructured":"Hiragata S, Ogawa T, Hayashi Y, Tyagi P, Seki S et al (2007) Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology 70:202\u2013208","journal-title":"Urology"},{"key":"2802_CR14","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1523\/JNEUROSCI.22-16-07147.2002","volume":"22","author":"N Dmitrieva","year":"2002","unstructured":"Dmitrieva N, Berkley KJ (2002) Contrasting effects of WIN 55212\u20132 on motility of the rat bladder and uterus. J Neurosci 22:7147\u20137153","journal-title":"J Neurosci"},{"key":"2802_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-7-31","volume":"7","author":"JS Walczak","year":"2011","unstructured":"Walczak JS, Cervero F (2011) Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol Pain 7:31","journal-title":"Mol Pain"},{"key":"2802_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pain.2006.04.001","volume":"124","author":"F Amaya","year":"2006","unstructured":"Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y et al (2006) Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain 124:175\u2013183","journal-title":"Pain"},{"key":"2802_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/nau.22442","volume":"33","author":"P Hedlund","year":"2014","unstructured":"Hedlund P (2014) Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction. Neurourol Urodyn 33:46\u201353","journal-title":"Neurourol Urodyn"},{"key":"2802_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1464-410X.2006.05989.x","volume":"97","author":"JI Gillespie","year":"2006","unstructured":"Gillespie JI, Markerink-van Ittersum M, De Vente J (2006) Interstitial cells and cholinergic signalling in the outer muscle layers of the guinea-pig bladder. BJU Int 97:379\u2013385","journal-title":"BJU Int"},{"key":"2802_CR19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B et al (2010) An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4\u201320","journal-title":"Neurourol Urodyn"},{"key":"2802_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O Lowry","year":"1951","unstructured":"Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"2802_CR21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/me.2009-0097","volume":"23","author":"PJ Brighton","year":"2009","unstructured":"Brighton PJ, McDonald J, Taylor AH, Challiss RA, Lambert DG et al (2009) Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. Mol Endocrinol 23:1415\u20131427","journal-title":"Mol Endocrinol"},{"key":"2802_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2004.01.023","volume":"487","author":"A Thomas","year":"2004","unstructured":"Thomas A, Ross RA, Saha B, Mahadevan A, Razdan RK et al (2004) 6\u201c-Azidohex-2\u201d-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. Eur J Pharmacol 487:213\u2013221","journal-title":"Eur J Pharmacol"},{"key":"2802_CR23","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1016\/S1569-9056(12)60367-4","volume":"11","author":"S Katagigiotis","year":"2012","unstructured":"Katagigiotis S, Kavia R, Gonzales G, Dimitriadis F, Ioannidis E et al (2012) Is there a local bladder effect of oral cannabinoid agonists? Eur Urol Suppl 11:e370\u2013e370a.","journal-title":"Eur Urol Suppl"},{"key":"2802_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2008.08.076","volume":"445","author":"FV Merriam","year":"2008","unstructured":"Merriam FV, Wang ZY, Guerios SD, Bjorling DE (2008) Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats. Neurosci Lett 445:130\u2013134","journal-title":"Neurosci Lett"},{"key":"2802_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA et al (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10\u201323","journal-title":"Brain Res"},{"key":"2802_CR26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/bph.12560","volume":"171","author":"C Stanley","year":"2014","unstructured":"Stanley C, O\u2019Sullivan SE (2014) Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 171:1361\u20131378","journal-title":"Br J Pharmacol"},{"key":"2802_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00429-012-0425-2","volume":"218","author":"G Veress","year":"2013","unstructured":"Veress G, Meszar Z, Muszil D, Avelino A, Matesz K et al (2013) Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct Funct 218:733\u2013750","journal-title":"Brain Struct Funct"},{"key":"2802_CR28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","volume":"410","author":"RI Wilson","year":"2001","unstructured":"Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588\u2013592","journal-title":"Nature"},{"key":"2802_CR29","doi-asserted-by":"crossref","first-page":"PL191","DOI":"10.1016\/S0024-3205(97)00690-5","volume":"61","author":"SJ Gatley","year":"1997","unstructured":"Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND et al (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61:PL191\u2013PL197","journal-title":"Life Sci"},{"key":"2802_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bph.12321","volume":"170","author":"TD Hill","year":"2013","unstructured":"Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG et al (2013) Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 170:679\u2013692","journal-title":"Br J Pharmacol"},{"key":"2802_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","volume":"163","author":"T Bisogno","year":"2003","unstructured":"Bisogno T, Howell F, Williams G, Minassi A, Cascio MG et al (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463\u2013468","journal-title":"J Cell Biol"},{"key":"2802_CR32","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819\u201310824","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-015-2802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-015-2802-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-015-2802-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T11:32:33Z","timestamp":1652959953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-015-2802-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2802"],"URL":"https:\/\/doi.org\/10.1007\/s00192-015-2802-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}